Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)

Clinical trial NCT06215586 · COMPLETED

Trial details

NCT number: NCT06215586
Sponsor: Cardurion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure Heart Failure Preserved Ejection Fraction Cardiovascular Diseases Heart Diseases

Start date: 2024-02-13
Primary completion: 2025-09-02
Enrollment: 303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.